Publication:

The REMEDEE-OCT Study: An Evaluation of the Bioengineered COMBO Dual-Therapy CD34 Antibody-Covered Sirolimus-Eluting Coronary Stent Compared With a Cobalt-Chromium Everolimus-Eluting Stent in Patients With Acute Coronary Syndromes: Insights From Optical Coherence Tomography Imaging Analysis

Date

Date

Date
2017
Journal Article
Published version

Citations

Citation copied

Jaguszewski, M., Aloysius, R., Wang, W., Bezerra, H. G., Hill, J., De Winter, R. J., Karjalainen, P. P., Verheye, S., Wijns, W., Lüscher, T. F., Joner, M., Costa, M., & Landmesser, U. (2017). The REMEDEE-OCT Study: An Evaluation of the Bioengineered COMBO Dual-Therapy CD34 Antibody-Covered Sirolimus-Eluting Coronary Stent Compared With a Cobalt-Chromium Everolimus-Eluting Stent in Patients With Acute Coronary Syndromes: Insights From Optical Coherence Tomography Imaging Analysis. JACC. Cardiovascular Interventions, 10, 489–499. https://doi.org/10.1016/j.jcin.2016.11.040

Abstract

Abstract

Abstract

OBJECTIVES The aim of the present study was to evaluate vascular healing of the bioengineered COMBO Dual Therapy Stent compared with a cobalt-chromium (CoCr) everolimus-eluting stent (EES) as assessed by optical coherence tomography in patients with acute coronary syndromes. BACKGROUND CD34+ cells promote endothelial repair after vascular injury. The bioengineered COMBO Dual Therapy Stent combines CD34+ cell-capturing technology with abluminal sirolimus release, but more data from clinical studies evaluating the vascular response a

Metrics

Views

64 since deposited on 2018-03-07
Acq. date: 2025-11-12

Additional indexing

Creators (Authors)

  • Jaguszewski, Milosz
    affiliation.icon.alt
  • Aloysius, Romila
    affiliation.icon.alt
  • Wang, Wei
    affiliation.icon.alt
  • Bezerra, Hiram G
    affiliation.icon.alt
  • Hill, Jonathan
    affiliation.icon.alt
  • De Winter, Robbert J
    affiliation.icon.alt
  • Karjalainen, Pasi P
    affiliation.icon.alt
  • Verheye, Stefan
    affiliation.icon.alt
  • Wijns, William
    affiliation.icon.alt
  • Lüscher, Thomas F
    affiliation.icon.alt
  • Joner, Michael
    affiliation.icon.alt
  • Costa, Marco
    affiliation.icon.alt
  • Landmesser, Ulf
    affiliation.icon.alt

Journal/Series Title

Journal/Series Title

Journal/Series Title

Volume

Volume

Volume
10

Number

Number

Number
5

Page range/Item number

Page range/Item number

Page range/Item number
489

Page end

Page end

Page end
499

Item Type

Item Type

Item Type
Journal Article

Dewey Decimal Classifikation

Dewey Decimal Classifikation

Dewey Decimal Classifikation

Language

Language

Language
English

Publication date

Publication date

Publication date
2017-03-13

Date available

Date available

Date available
2018-03-07

Publisher

Publisher

Publisher

ISSN or e-ISSN

ISSN or e-ISSN

ISSN or e-ISSN
1876-7605

OA Status

OA Status

OA Status
Closed

Free Access at

Free Access at

Free Access at
DOI

PubMed ID

PubMed ID

PubMed ID

Metrics

Views

64 since deposited on 2018-03-07
Acq. date: 2025-11-12

Citations

Citation copied

Jaguszewski, M., Aloysius, R., Wang, W., Bezerra, H. G., Hill, J., De Winter, R. J., Karjalainen, P. P., Verheye, S., Wijns, W., Lüscher, T. F., Joner, M., Costa, M., & Landmesser, U. (2017). The REMEDEE-OCT Study: An Evaluation of the Bioengineered COMBO Dual-Therapy CD34 Antibody-Covered Sirolimus-Eluting Coronary Stent Compared With a Cobalt-Chromium Everolimus-Eluting Stent in Patients With Acute Coronary Syndromes: Insights From Optical Coherence Tomography Imaging Analysis. JACC. Cardiovascular Interventions, 10, 489–499. https://doi.org/10.1016/j.jcin.2016.11.040

Closed
Loading...
Thumbnail Image

Permanent URL

Permanent URL

Permanent URL
No files available